Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2003
10/15/2003EP1351954A1 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives
10/15/2003EP1351953A1 Quinoline derivatives as nk-3 antagonists
10/15/2003EP1351952A2 Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
10/15/2003EP1351951A2 Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
10/15/2003EP1351950A2 Isoindolyl and isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders
10/15/2003EP1351939A1 Coupler/developer and coupler/coupler hybrid dyes and coupler/developer and coupler/coupler hybrid dye intermediates
10/15/2003EP1351938A1 Phenyl derivatives
10/15/2003EP1351936A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351935A1 Aryl piperidine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351932A2 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents
10/15/2003EP1351928A2 Novel n(phenylsulphonyl)glycine derivatives and their therapeutic use
10/15/2003EP1351691A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/15/2003EP1351689A2 Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases
10/15/2003EP1351688A1 Urotensin-ii receptor antagonists
10/15/2003EP1351687A2 Urotensin-ii receptor antagonists
10/15/2003EP1351686A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
10/15/2003EP1246799B1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/15/2003EP1135370B1 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
10/15/2003EP1098890B1 Dihydrotriazolone derivatives as pesticides
10/15/2003EP1051374B1 The use of compressed carbon dioxide in chemical reactions
10/15/2003EP0950047B1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
10/15/2003EP0861246B1 Prolyl endopeptidase inhibitors, their preparation and their pharmaceutical use
10/15/2003EP0855391B1 Novel isoquinoline derivatives
10/15/2003EP0797575B1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
10/15/2003CN1449386A Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
10/15/2003CN1449384A Novel ester or amide derivatives
10/15/2003CN1449382A Polyarylcarboxamides useful as lipid lowering agents
10/15/2003CN1449280A Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities
10/15/2003CN1124269C Substituted pryimidine compounds and their use
10/15/2003CN1124266C Azacyclooctane and heptane derivatives, their preparation and usein therapy
10/14/2003US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
10/14/2003US6632828 Substituted imidazole neuropeptide Y Y5 receptor antagonists
10/14/2003US6632825 Picornaviral 3C protease enzyme inhibitors; amide ester or amide acid derivatives
10/14/2003US6632823 Substituted pyridine compounds useful as modulators of acetylcholine receptors
10/14/2003US6632821 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
10/14/2003US6632815 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades
10/14/2003US6632812 Substituted lactams as inhibitors of Aβ protein production
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/14/2003US6632809 Gyrase inhibitors and uses thereof
10/14/2003CA2291994C Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/14/2003CA2205509C Microbicidal triazolyl derivatives
10/14/2003CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/09/2003WO2003082859A1 Indolylmaleimide derivatives
10/09/2003WO2003082858A1 Crystalline forms of rabeprazole sodium
10/09/2003WO2003082857A2 Lansoprazole polymorphs and processes for preparation thereof
10/09/2003WO2003082856A1 Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists
10/09/2003WO2003082855A1 Anti-inflammatory agent
10/09/2003WO2003082854A1 1-n-aminobenzimidazole derivatives
10/09/2003WO2003082853A1 New compounds
10/09/2003WO2003082833A1 1,2,4-triazole derivatives with cannabinoid properties
10/09/2003WO2003082832A2 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003WO2003082831A1 4-anilino quinazoline derivatives as antiproliferative agents
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082828A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082333A1 Remedy for sleep disturbance
10/09/2003WO2003082290A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082272A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003WO2003082268A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003WO2003082191A2 Substituted 2,3-diphenyl pyridines
10/09/2003WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003WO2003082186A2 Use of benzimidazole analogs in the treatment of cell proliferation
10/09/2003WO2002069905A3 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
10/09/2003WO2001079189A3 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/09/2003US20030191340 Catalytic compositions and methods for asymmetric allylic alkylation
10/09/2003US20030191317 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
10/09/2003US20030191314 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
10/09/2003US20030191311 Imidazole derivatives
10/09/2003US20030191308 Quinazoline compounds
10/09/2003US20030191307 2,4-Diaminopyrimidine compounds useful as immunosuppressants
10/09/2003US20030191213 Novel flame retarding compounds
10/09/2003US20030191171 Insecticidal and acaricidal agent
10/09/2003US20030191168 Binding to nucleic acids
10/09/2003US20030191164 Propane-1,3-dione derivatives
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191160 Aids therapy; calibration efficiency of benzimidazole compound
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/09/2003US20030191155 Triazole derivatives
10/09/2003US20030191153 Antithrombotic amides
10/09/2003US20030191133 Indole derivatives useful for the treatment of CNS disorders
10/09/2003US20030191132 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191129 Antitumor agents
10/09/2003US20030191126 Psychological disorders; antidepressants
10/09/2003US20030191125 Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof
10/09/2003US20030191124 Derivatives of sulphonamides, their preparation and use as medicaments
10/09/2003US20030191115 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
10/09/2003US20030191113 For agriculture
10/09/2003US20030191112 Novel substituted piperidines
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191107 3-(Imidazolyl)-2-aminopropanoic acids
10/09/2003US20030191098 Synergistic mixture of thalidomide antiinflammatory agnets
10/09/2003US20030191069 2-oxoquinoline compounds and pharmaceutical uses thereof
10/09/2003US20030191068 Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
10/09/2003US20030190743 Enzymatic process for the resolution of enantiomeric mixtures of beta-lactams
10/09/2003US20030190540 Photoconductive layer containing azo compound; electrostaticlatent image
10/09/2003US20030189191 Fluorescent maleimides and uses thereof
10/09/2003CA2480890A1 1-n-aminobenzimidazole derivatives
1 ... 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 ... 1080